Risk of COVID-19 and its complications in patients with atopic dermatitis undergoing dupilumab treatment—a population-based cohort study두필루맙 치료를 받는 아토피 피부염 환자의 코로나19 위험 및 합병증 - 인구 기반 코호트 연구Original Article Published on 2021-10-132022-09-12 Journal: Immunologic research [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] 95% CI AD atopic dermatitis azathioprine biologics comparable Complication complications conducted coronavirus disease Corticosteroids COVID-19 COVID-19 complication COVID-19 complications Dupilumab elevated Hospitalization incidence of COVID-19 incidence rate increased risk Infection Mortality mycophenolate mycophenolate mofetil pandemic Patient patients treated phototherapy population-based cohort risk Safe SARS-COV-2 infection systemic corticosteroid treated [DOI] 10.1007/s12026-021-09234-z PMC 바로가기 [Article Type] Original Article
Vitamin D supplementation prior to or during COVID-19 associated with better 3-month survival in geriatric patients: Extension phase of the GERIA-COVID studyClinical Trial Published on 2021-10-012022-10-05 Journal: The Journal of steroid biochemistry and molecular [Category] SARS, 신약개발, 임상, [키워드] age Antibiotics Cardiomyopathy comparator Concentration COVID-19 COVID-19 patients defined determine Epidemiology extension functional hazard ratio Health involved malignancies Mortality Older Older adults participant patients hospitalized SARS-CoV-2 Sex survival survived systemic corticosteroid Treatment Vitamin D vitamin D supplement Vitamin D3 [DOI] 10.1016/j.jsbmb.2021.105958 PMC 바로가기 [Article Type] Clinical Trial
Tocilizumab and Systemic Corticosteroids in the Management of Patients with COVID-19: A Systematic Review and Meta-AnalysisCOVID-19 환자 관리에서 토실리주맙과 전신 코르티코스테로이드: 체계적인 검토 및 메타 분석Meta-Analysis Published on 2021-09-012022-09-12 Journal: International Journal of Infectious Diseases [Category] SARS, 진단, [키워드] 95% confidence interval adjusted association Combination coronavirus COVID-19 COVID-19 patients data extraction disease effective Efficacy estimate Health lower mortality mortality rate New coronavirus not differ outcome performed randomized trial Record review risk risk of bia SCT searched severe COVID-19 Standard of care study outcomes subject systemic systemic corticosteroid systemic corticosteroid therapy TCZ therapy Tocilizumab Treatment were used [DOI] 10.1016/j.ijid.2021.07.021 PMC 바로가기 [Article Type] Meta-Analysis
Systemic corticosteroids for the treatment of COVID-19COVID-19 치료를 위한 전신 코르티코스테로이드Review Published on 2021-08-162022-09-11 Journal: The Cochrane database of systematic reviews [Category] SARS, 임상, [키워드] 95% CI 95% confidence interval acute respiratory syndrome adjust adverse event adverse events age all-cause mortality analysed Analysis applicability approach arising Arm Asymptomatic asymptomatic infection baseline benefit caution CENTRAL certainty certainty of evidence change citation Cochrane COVID-19 Study Register Combination comparison Comparisons composite endpoint control group coronavirus disease coronavirus diseases Corticosteroid Corticosteroids COVID-19 Data collection death Descriptive statistics Dexamethasone Diagnosis direction disease disease severity dosage dosages dose doses doses of corticosteroids effective Effects eligible endpoints estimate Ethnicity evaluated Evidence excluded Factor FIVE Follow-up Gender heterogeneous high risk hospital-acquired infections hospitalised hyper-inflammation identify include index individual Inhaled inhaled corticosteroids inherent invasive Invasive mechanical ventilation invasive ventilation life limitation long-COVID majority median medRxiv methodology Methylprednisolone Middle East Middle East respiratory syndrome Mild Mild disease Mortality MOST New nine non-hospitalised occurred Other outcomes outcome outcomes Outpatient outpatients participant Participants Patient people with COVID-19 Placebo Population Quality Quality of life randomisation randomised randomised controlled trial Randomised controlled trials RCT RCTs reduce reduction in regimen reported Respiratory Support risk risk difference risk of bia risk ratio Safe Science Citation Index searched Selection Serious Adverse Events Severe acute respiratory syndrome standard care subgroup subgroups subsequent suspected diagnosis symptomatic symptomatic COVID-19 syndrome systematic review systemic systemic corticosteroid systemic corticosteroids the WHO therapy topical treat Treatment Trial Ventilation ventilator-free day Ventilator-free days Web of Science WHO ICTRP [DOI] 10.1002/14651858.CD014963 PMC 바로가기 [Article Type] Review
Coronavirus disease 2019 in solid organ transplant recipients in the setting of proactive screening and contact tracing of QatarResearch Article Published on 2021-08-102022-10-28 Journal: Qatar Medical Journal [Category] COVID-19, [키워드] Acute kidney injury association Asymptomatic COVID-19 asymptomatic patient clinical Clinical data clinical experience cohorts Contact tracing continuous variable coronavirus Coronavirus disease 2019 cough COVID-19 demographic diagnosed died discharged home drug-drug interaction Electronic health records females Fever Follow-up Frequency General population ICU immunosuppressive initial intensive care International Invasive mechanical ventilation kidney laboratory-confirmed liver maintenance median median age Middle East organ transplantation outcome Patient patients percentages presenting symptoms Qatar recipient required SARS-CoV-2 solid organ transplant SOT still hospitalized systemic corticosteroid Therapies therapy transplantation with COVID-19 [DOI] 10.5339/qmj.2021.23 PMC 바로가기 [Article Type] Research Article
Case Report: COVID-19-associated Rhinosinusitis Mucormycosis Caused by Rhizopus arrhizus : A Rare but Potentially Fatal Infection Occurring After Treatment with Corticosteroids사례보고 : Rhizopus arrhizus로 인한 COVID-19 관련 비염 물질염 점액증 : 코르티코 스테로이드로 치료 한 후 발생하는 희귀하지만 잠재적으로 치명적인 감염Case Reports Published on 2021-08-082022-09-10 Journal: The American Journal of Tropical Medicine and Hygi [Category] SARS, 치료기술, [키워드] Admission association Bacterial caused conditions Corticosteroids COVID-19 COVID-19 patient diabete diabetes Diagnosis discharge DNA Early detection facial facial swelling Follow-up Frequency fungal fungal infections increasingly information invasive Invasive pulmonary aspergillosis management Mucormycosis numbness pulmonary aspergillosis rhinosinusitis Rhizopus Sequencing spacer swelling systemic corticosteroid systemic corticosteroids the patient transcribed Treatment with COVID-19 Wuhan Wuhan, China [DOI] 10.4269/ajtmh.21-0359 PMC 바로가기 [Article Type] Case Reports
The Influence of Corticosteroids, Immunosuppressants and Biologics on Patients With Inflammatory Bowel Diseases, Psoriasis and Rheumatic Diseases in the Era of COVID-19: A Review of Current EvidenceImmunology Published on 2021-07-082022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, SARS, [키워드] 2019-nCoV anti-TNF antiviral immune response Autoimmune benefit biologics Corticosteroids COVID-19 COVID-19 epidemic current Cytokine storm death decision Hospitalization ICU Immune-mediated inflammatory diseases immunocompromised status immunomodulator immunomodulators Immunosuppressant Infection Inflammatory bowel disease influence lower risk mechanism Mortality pathway Patient patients patients treated potential risk psoriasis review rheumatic disease risk SARS-CoV-2 significant changes in suggested systemic corticosteroid therapy treated use of corticosteroids Ventilation [DOI] 10.3389/fimmu.2021.677957 PMC 바로가기 [Article Type] Immunology
Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis planCOVID-19 및 중증 저산소증(COVID STEROID 2) 환자에 대한 덱사메타손의 고용량 및 저용량 시험: 프로토콜 및 통계 분석 계획Comparative Study Published on 2021-07-012022-09-11 Journal: Acta Anaesthesiologica Scandinavica [Category] SARS, 임상, [키워드] adjusted all-cause mortality analysed benefit blinded clinical benefit clinical trial coronavirus disease Coronavirus disease 2019 Corticosteroid Corticosteroids COVID COVID-19 COVID-19 patient days alive death Denmark Dexamethasone dose doses of corticosteroid Evidence Healthcare system Healthcare systems hospital hypoxia implication include India inflammatory lung disease International Invasive mechanical ventilation investigator-initiated life low-dose low-dose corticosteroid lower dose Lung diseases mean difference median offer outcome outlined pandemic Patient patients patients with COVID-19 present Primary outcome protocol Quality of life randomised renal replacement therapy replacement therapy reported secondary Secondary outcomes serious adverse reaction Serious adverse reactions severe COVID-19 severe hypoxia Society Statistical analysis plan steroid Stratification stratified Support Switzerland systemic systemic corticosteroid systemic corticosteroids Trial variable with COVID-19 [DOI] 10.1111/aas.13795 PMC 바로가기 [Article Type] Comparative Study
Clinical Outcomes of Severe COVID-19 Patients Admitted to an Intermediate Respiratory Care UnitMedicine Published on 2021-07-012022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] 95%CI age Chronic kidney disease chronic respiratory chronic respiratory condition clinical Clinical outcome clinical outcomes condition COVID-19 Cox proportional hazard death dose Follow-up hazard health-care High-flow nasal cannula ICU IMCU intensive care intermediate intermediate care unit IQR lower risk male management median age Mortality mortality rate multivariable Non-invasive non-invasive ventilation Patient Patient care Pneumonia protective effect reducing renal required resource respiratory Respiratory care Respiratory Support Retrospective study risk factor severe COVID-19 patient stratified survival systemic corticosteroid transfer transferred Treatment unit was used [DOI] 10.3389/fmed.2021.711027 PMC 바로가기 [Article Type] Medicine
COVID-19 pneumonia in Galicia (Spain): Impact of prognostic factors and therapies on mortality and need for mechanical ventilation갈리시아의 Covid-19 폐렴 (스페인) : 예후 요인 및 치료가 사망률 및 기계적 환기 필요에 미치는 영향Observational Study Published on 2021-06-232022-09-10 Journal: PLoS ONE [Category] MERS, 임상, 치료제, [키워드] 95% CI 95% confidence interval Admission Analysis carried Charlson index Corticosteroids COVID-19 COVID-19 pneumonia CRP death died healthcare help higher risk hospital Hospital admission hospitals Hydroxychloroquine identify Impact impacted logistic regression model male mechanical ventilation Mortality multicenter multivariable logistic regression Multivariable logistic regression analysis observational study outcome Patient patients hospitalized Pneumonia Prognostic factor quartile reached reducing Result risk factor Risk factors sensitivity analysis significantly systemic corticosteroid therapeutic intervention therapeutic interventions therapy Tocilizumab was performed with COVID-19 [DOI] 10.1371/journal.pone.0253465 PMC 바로가기 [Article Type] Observational Study